DMPX: Difference between revisions
Appearance
Content deleted Content added
KolbertBot (talk | contribs) m Bot: HTTP→HTTPS (v477) |
Zakblade2000 (talk | contribs) No edit summary |
||
Line 49: | Line 49: | ||
[[Category:Designer drugs]] |
[[Category:Designer drugs]] |
||
[[Category:Vasoconstrictors]] |
[[Category:Vasoconstrictors]] |
||
[[Category:Alkynes]] |
Revision as of 13:05, 28 May 2018
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.162.258 |
Chemical and physical data | |
Formula | C10H10N4O2 |
Molar mass | 218.212 g/mol g·mol−1 |
3D model (JSmol) | |
| |
|
DMPX (3,7-dimethyl-1-propargylxanthine) is a caffeine analog which displays affinity to A2 adenosine receptors, in contrast to the A1 subtype receptors.[1] DMPX had 28× and 15× higher potency than caffeine in blocking peripheral and central NECA-responses. The locomotor stimulation caused by DMPX (ED50 10 μmol/kg) was similarly higher than caffeine.[1]
See also
- DPCPX
- 8-PT
- CPX (8-CPT)
- 8-Chlorotheophylline
- Theophylline
References
- ^ a b 3,7-Dimethyl-1-propargylxanthine: a potent and selective in vivo antagonist of adenosine analogs. Life Sci. 1988;43(21):1671-84. PMID 3193854